Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,822Revenue $M2,943Net Margin (%)14.9Z-Score5.2
Enterprise Value $M8,273EPS $4.0Operating Margin %20.7F-Score6
P/E(ttm))21.9Cash Flow Per Share $4.4Pre-tax Margin (%)20.8Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %13.7Quick Ratio1.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %10.3Current Ratio2.2Lower Leverage y-yN
Price/Cash Flow16.0y-y EBITDA Growth Rate %-1.1ROA % (ttm)12.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)25.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M104ROI % (ttm)25.1Gross Margin Increase y-yY

Gurus Latest Trades with VAR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VARJohn Hussman 2014-03-31 Buy 0.94%$77.34 - $84.96
($81.89)
$ 84.273%New holding, 150000 sh.150,000
VARRay Dalio 2014-03-31 Reduce-0.01%$77.34 - $84.96
($81.95)
$ 84.273%Reduce -25.25%29,598
VARJohn Hussman 2013-12-31 Sold Out -0.41%$72.5 - $79.84
($75.95)
$ 84.2711%Sold Out0
VARJohn Hussman 2013-09-30 Buy 0.41%$66.3 - $76.27
($72.25)
$ 84.2717%New holding, 100000 sh.100,000
VARCharles Brandes 2013-09-30 Buy 0.12%$66.3 - $76.27
($72.25)
$ 84.2717%New holding, 122218 sh.122,218
VARRay Dalio 2013-09-30 Reduce-0.01%$66.3 - $76.27
($72.25)
$ 84.2717%Reduce -39.25%36,912
VARRay Dalio 2013-06-30 Add0.01%$64.02 - $72.78
($68.3)
$ 84.2723%Add 38.63%60,756
VARMario Gabelli 2013-06-30 Sold Out $64.02 - $72.78
($68.3)
$ 84.2723%Sold Out0
VARJoel Greenblatt 2013-03-31 Add0.07%$68.66 - $75.25
($72.28)
$ 84.2717%Add 65.73%47,672
VARRay Dalio 2013-03-31 Buy 0.03%$68.66 - $75.25
($72.28)
$ 84.2717%New holding, 43827 sh.43,827
VARJohn Hussman 2013-03-31 Sold Out -0.25%$68.66 - $75.25
($72.28)
$ 84.2717%Sold Out0
VARMario Gabelli 2012-12-31 Reduce$57.08 - $72.35
($66.56)
$ 84.2727%Reduce -30.95%5,355
VARJohn Hussman 2012-12-31 Reduce-0.17%$57.08 - $72.35
($66.56)
$ 84.2727%Reduce -46.8%133,000
VARJoel Greenblatt 2012-12-31 Reduce-0.06%$57.08 - $72.35
($66.56)
$ 84.2727%Reduce -33.84%28,764
VARJoel Greenblatt 2012-09-30 Add0.1%$53.73 - $61.76
($58.54)
$ 84.2744%Add 130.72%43,476
VARJohn Hussman 2012-09-30 Reduce-1.12%$53.73 - $61.76
($58.54)
$ 84.2744%Reduce -80%250,000
VARJoel Greenblatt 2012-06-30 Buy 0.08%$57.15 - $68.81
($63.01)
$ 84.2734%New holding, 18844 sh.18,844
VARRay Dalio 2012-06-30 Sold Out -0.04%$57.15 - $68.81
($63.01)
$ 84.2734%Sold Out0
VARRay Dalio 2012-03-31 Buy 0.04%$64.48 - $71.7
($63.77)
$ 84.2732%New holding, 40865 sh.40,865
VARRay Dalio 2011-12-31 Sold Out -0.15%$50.1 - $67.13
($59.39)
$ 84.2742%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VAR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VAR John Hussman 2014-03-31150,0000.140.94New Buy
VAR Charles Brandes 2014-03-31129,4120.120.14-0.28%
VAR Joel Greenblatt 2014-03-3138,4270.040.05-14.9%
VAR Ray Dalio 2014-03-3129,5980.030.02-25.25%
Premium Most recent portfolio changes are included for Premium Members only!


VAR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys. 2014-07-14Sell641$85.12-0.96view
KUO JOHN WSVP, Gen Counsel and Secretary 2014-07-11Sell605$84.96-0.78view
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys. 2014-07-09Sell775$84.69-0.46view
KUO JOHN WSVP, Gen Counsel and Secretary 2014-07-09Sell582$85-0.82view
FINNEY ELISHA WExec VP and CFO 2014-07-01Sell20,000$83.860.52view
KUO JOHN WSVP, Gen Counsel and Secretary 2014-06-23Sell1,745$85-0.82view
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys. 2014-06-16Sell1,416$82.422.28view
KUO JOHN WSVP, Gen Counsel and Secretary 2014-06-11Sell606$81.383.59view
FINNEY ELISHA WExec VP and CFO 2014-06-02Sell10,000$82.352.37view
KUO JOHN WSVP, Gen Counsel and Secretary 2014-05-12Sell605$82.791.82view

Press Releases about VAR :

Quarterly/Annual Reports about VAR:

News about VAR:

Articles On GuruFocus.com
Bearish Investor John Hussman's 5 Top New Stock Buys May 02 2014 
David Rolfe Comments on Varian Medical Systems Apr 18 2014 
David Rolfe's Wedgewood Partners Q1 2014 Investor Letter Apr 18 2014 
David Rolfe's Wedgewood Partners Fourth Quarter 2013 Client Letter Jan 22 2014 
comment on VAR Mar 03 2013 
Wedgewood Partners' David Rolfe Comments on Varian Medical Systems Nov 12 2012 
Weekly CFO Sells Highlight: CMCSA, MM, PIR, VAR, SPRT Nov 03 2012 
Introducing New Guru David Rolfe, Added to EXPD, CTSH, VAR, QCOM in Q2 Sep 04 2012 
simple business high Feb 24 2012 
Weekly CEO Sells Highlight: Golub Capital BDC Inc, PNC Financial Services Group Inc, Meritor and Var Jan 08 2012 


More From Other Websites
Midday Glance: Health Care Equipment companies Jul 21 2014
Midday Glance: Health Care Equipment companies Jul 21 2014
Will Varian Medical Systems (VAR) Surprise This Earnings? Jul 21 2014
Early Glance: Health Care Equipment companies Jul 21 2014
Early Glance: Health Care Equipment companies Jul 21 2014
Varian Medical Systems Receives FDA 510(k) Clearance for Calypso® Soft Tissue Beacon® Transponder Jul 21 2014
8:03 am Varian Medical receives FDA 510(k) clearance for Calypso soft tissue Beacon transponder Jul 21 2014
Varian Medical Systems Receives FDA 510(k) Clearance for Calypso® Soft Tissue Beacon® Transponder Jul 21 2014
Varian Medical's Radiosurgery Offers Precise Cancer Cure Jul 18 2014
Knowledge-Based Treatment Planning for Radiation Oncology to be Highlighted at the 2014 American... Jul 18 2014
Knowledge-Based Treatment Planning for Radiation Oncology to be Highlighted at the 2014 American... Jul 18 2014
Researchers Show that the Edge™ Radiosurgery System from Varian Medical Systems Can Target Cancer... Jul 17 2014
Researchers Show that the Edge™ Radiosurgery System from Varian Medical Systems Can Target Cancer... Jul 17 2014
Varian to Highlight Software that Augments Quality Assurance Processes in Radiation Oncology at the... Jul 16 2014
Varian to Highlight Software that Augments Quality Assurance Processes in Radiation Oncology at the... Jul 16 2014
Varian Medical Systems Holds Developer Workshop for Researchers Working on Next Generation... Jul 15 2014
Varian Medical's Linear Accelerator Debuts in India Jul 15 2014
Varian Medical Systems Holds Developer Workshop for Researchers Working on Next Generation... Jul 15 2014
Tax Reform, Not Tax Inversions, Will Rescue The U.S. Pharma, Bio, And Medical-Device Industries Jul 15 2014
Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator Jul 14 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide